Filip Wiberg

Stock Analyst at Pareto

(n/a)
# 4,907
Out of 5,000 analysts
2
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Filip Wiberg

Swedish Orphan Biovitrum AB (publ)
Jun 29, 2026
Downgraded: Hold
Price Target: kr 470.00
Current: kr 436.00
Upside: +7.80%
Xvivo Perfusion AB (publ)
Mar 25, 2025
Upgraded: Buy
Price Target: kr 460.00
Current: kr 238.00
Upside: n/a